Posted on February 11, 20262/11/26
EVERSANA Names Monica Avram Executive Vice President and Chief Legal Officer to Advance Governance, Compliance, and Enterprise Growth
Posted on November 6, 202511/6/25
EVERSANA Named AI Company of the Year by BioTech Breakthrough
Posted on October 23, 202510/23/25
OWP Pharmaceuticals Selects EVERSANA to Support U.S. Launch of SUBVENITE® (lamotrigine) Oral Suspension
Posted on October 16, 202510/16/25
Citius Oncology Signs Exclusive Commercialization Agreement with EVERSANA to Support Planned Q4 2025 Launch of LYMPHIR™
Posted on September 11, 20259/11/25
EVERSANA Named by Precigen for U.S. Commercialization of PAPZIMEOS
Posted on August 26, 20258/26/25
EVERSANA Merges with Waltz Health to Create a New Force in Pharma Commercialization and Prescription Drug Access
Posted on August 4, 20258/4/25
EVERSANA Announces Development of End-to-End AI-Powered Life Sciences Marketing Agency Built on Google Cloud Technology
Posted on July 17, 20257/17/25
EVERSANA Unveils EVERSANA ORCHESTRATE PV, An AI-Propelled Solution to Shape the Future of Pharmacovigilance
Posted on July 15, 20257/15/25
EVERSANA Announces Enterprise Advancement to ‘Pharmatize AI” With the Launch of the EVERSANA AI Accelerator
Posted on June 11, 20256/11/25